|
Naphthalene diisocyanate | CAS 3173-72-6 | ||
C10H6(NCO)2 | RTECS NQ9600000 | ||
Synonyms & Trade Names 1,5-Diisocyanatonaphthalene; 1,5-Naphthalene diisocyanate; 1,5-Naphthalene ester of isocyanic acid; NDI |
DOT ID & Guide |
Exposure Limits |
NIOSH REL: TWA 0.040 mg/m3 (0.005 ppm) C 0.170 mg/m3 (0.020 ppm) [10-minute] | ||
OSHA PEL: none | |||
IDLH N.D. | Conversion 1 ppm = 8.60 mg/m3 |
Physical Description White to light-yellow, crystalline flakes. |
|||
MW: 210.2 |
BP: 505°F |
MLT: 261°F |
Sol: ? |
VP(75°F): 0.003 mmHg |
IP: ? |
|
Sp.Gr: ? |
Fl.P(oc): 311°F |
UEL: ? |
LEL: ? |
|
Combustible Solid | |||
Incompatibilities & Reactivities None reported |
Measurement Methods OSHA PV2046 |
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: Daily |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash immediately Breathing: Respiratory support Swallow: Medical attention immediately |
Respirator Recommendations
NIOSH Up to 0.05 ppm: (APF = 10) Any supplied-air respirator* Up to 0.125 ppm: (APF = 25) Any supplied-air respirator operated in a continuous-flow mode* Up to 0.25 ppm: (APF = 50) Any self-contained breathing apparatus with a full facepiece/(APF = 50) Any supplied-air respirator with a full facepiece Up to 1 ppm: (APF = 2000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode Emergency or planned entry into unknown concentrations or IDLH conditions: (APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode/(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus Escape: (APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister/Any appropriate escape-type, self-contained breathing apparatus |
|
Exposure Routes inhalation, ingestion, skin and/or eye contact | |
Symptoms Irritation eyes, nose, throat; respiratory sensitization, cough, pulmonary secretions, chest pain, dyspnea (breathing difficulty); asthma | |
Target Organs
Eyes, respiratory system |
See also: INTRODUCTION |